Rac inactivation decreases cell adhesion strength in chronic myeloid leukaemia
Chronic myeloid leukemia is a hematological malignancy characterized by the reciprocal translocation between chromosomes 9 and 22, resulting in the expression of the constitutively active tyrosine kinase BCR-ABL. The treatment of chronic myeloid leukemia by the tyrosine kinase inhibitior, imatinib,...
| 主要作者: | |
|---|---|
| 其他作者: | |
| 格式: | Final Year Project (FYP) |
| 語言: | English |
| 出版: |
2011
|
| 主題: | |
| 在線閱讀: | http://hdl.handle.net/10356/45681 |